We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current PCSA market cap is 2.64M. The company's latest EPS is USD -9.0307 and P/E is -0.24.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.06M | -13.07M | -4.11M | -2.72M | -2.17M |
| Net Income | -6.02M | -13.01M | -4.02M | -2.61M | -2.08M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.94M | -15.14M | -12.13M | -27.53M | -11.46M |
| Net Income | -3.36M | -14.41M | -11.43M | -27.42M | -11.12M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 18.6M | 8.62M | 12.43M | 10.09M | 8.08M |
| Total Liabilities | 1.36M | 1.15M | 2.29M | 930k | 915k |
| Total Equity | 17.24M | 7.47M | 10.14M | 9.16M | 7.17M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 10.88M | 25.21M | 26.46M | 8.62M | 5.79M |
| Total Liabilities | 2.87M | 2.28M | 979k | 1.15M | 798k |
| Total Equity | 8.01M | 22.94M | 25.49M | 7.47M | 4.99M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.11M | -9.61M | -2.11M | -4.18M | -5.94M |
| Investing | N/A | N/A | N/A | N/A | -3k |
| Financing | -335k | -389k | 6.35M | 6.35M | 6.3M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.75M | -3.14M | -8.72M | -9.61M | -8.06M |
| Investing | N/A | N/A | N/A | N/A | -3k |
| Financing | 1.7M | 17.87M | 9.8M | -389k | 6.27M |
| Market Cap | 2.64M |
| Price to Earnings Ratio | -0.24 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.57 |
| Price to Book Ratio | 0.54 |
| Dividend Yield | - |
| Shares Outstanding | 1.23M |
| Average Volume (1 week) | 589.71k |
| Average Volume (1 Month) | 3.84M |
| 52 Week Change | -83.54% |
| 52 Week High | 18.00 |
| 52 Week Low | 1.40 |
| Spread (Intraday) | 0.11 (4.98%) |
| Company Name | Processa Pharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
